Moderna files quarterly report (10-Q) for the period ended Jun 30, 2026

Moderna filed its quarterly report on Form 10-Q with the SEC on Jul 31, 2026, 4:17 PM ET, covering the quarter ended Jun 30, 2026. It reports fiscal Q2 2026 results.

• Revenue: $145.0M (+2.1% from $142.0M a year earlier)
• Operating income: −$815.0M (vs −$907.0M a year earlier)
• Net income: −$782.0M (vs −$825.0M a year earlier)
• Diluted EPS: $-1.97 (vs $-2.13 a year earlier)
• Form 10-Q accepted by EDGAR Jul 31, 2026, 4:17 PM ET
• Accession number 0001682852-26-000150

SEC filing 10-Q · accession 0001682852-26-000150 · sec.gov ↗